Dr. Hernando Lopez-Bertoni was born in Paraguay, South America, and moved to the United States after completing high school to pursue a career in science in the United States of America. Early on in his career, he took an interest in personalized medicine and molecular therapies, which he strongly believe in the future of medicine. The long-term goal of his research is to understand the molecular mechanisms involved in regulating stemness and differentiation in neoplastic and non-neoplastic neural cells. Dr. Hernando group wants to better understand Glioblastoma Multiforme (GBM) by studying the molecular mechanism by which these cells acquire a stem-like phenotype and use this knowledge to develop new ways to treat and diagnose the disease. His group wants to expand upon our current experimental model and conceptual paradigms and identify miRNAs and tumor-suppressive pathways capable of inhibiting GBM stem-like tumor-propagating phenotype and apply that knowledge to develop new therapeutic approaches.